Page 455 - Mad Hedge Fund Trader

Unveiling Google's New Enterprise Suite and Groundbreaking AI Chip - A Transformative Leap Forward

Introduction

On August 29, 2023, Google made seismic waves across the tech industry by introducing its highly anticipated Enterprise Suite, coupled with the announcement of a groundbreaking AI chip. This pivotal moment in technology marks Google's renewed commitment to empowering businesses with cutting-edge tools and solutions while pushing the boundaries of artificial intelligence hardware. The synergistic impact of the Enterprise Suite and the AI chip promises to reshape the landscape of enterprise operations, paving the way for unprecedented innovation, efficiency, and growth.

Google's Enterprise Suite: A Holistic Approach to Business Solutions

The Google Enterprise Suite is an integrated collection of software and services designed to cater to the diverse needs of modern businesses. It offers an expansive array of tools, ranging from productivity and communication applications to advanced data analytics and security solutions. This suite is a testament to Google's deep understanding of the evolving demands of enterprises in an increasingly digitized world.

Productivity and Collaboration Tools: The Enterprise Suite integrates the power of Google Workspace, providing businesses with tools like Gmail, Google Docs, Sheets, and Slides. What sets this suite apart is its enhanced collaboration features, allowing teams to seamlessly work together on projects, regardless of their physical locations. Real-time co-authoring, AI-powered suggestions, and integration with other popular enterprise software enable streamlined workflows and enhanced productivity.
Advanced Analytics: The Enterprise Suite brings forth advanced data analytics capabilities powered by Google Cloud's BigQuery. Businesses can harness the potential of big data to extract actionable insights and make data-driven decisions. This is a substantial leap forward in the quest to convert raw information into a strategic advantage.
Enhanced Security Solutions: With an increasing number of cyber threats targeting businesses, the Enterprise Suite prioritizes security. Google's advanced security infrastructure, including robust encryption, multi-factor authentication, and real-time threat detection, fortifies the suite against potential breaches.
AI-Powered Customer Engagement: One of the standout features of the Enterprise Suite is its AI-driven customer engagement tools. These enable businesses to provide personalized experiences to their customers, using data to understand their preferences and behaviors. This creates stronger connections, fosters loyalty, and enhances brand reputation.
Unified Communication: The suite integrates Google Meet, offering businesses a secure and high-quality video conferencing platform. With seamless integration across devices, teams can connect and collaborate effortlessly, fostering meaningful communication regardless of geographical boundaries.

The QuantumLeap AI Chip: Redefining Artificial Intelligence Processing

Alongside the Enterprise Suite, Google unveiled its groundbreaking AI chip, QuantumLeap. This chip represents a quantum leap indeed, as it marks a substantial milestone in the development of AI-specific hardware, transcending the boundaries of conventional processing.

Quantum Processing Power: QuantumLeap is designed to accelerate AI computations by leveraging quantum processing capabilities. Traditional computing methods are bound by the limitations of classical bits, but QuantumLeap harnesses the power of quantum bits (qubits) to process a multitude of calculations simultaneously. This results in an exponential increase in processing speed for AI algorithms, making complex tasks achievable in record time.
Deep Learning Optimization: Deep learning, a subset of AI, requires extensive computational power. QuantumLeap's architecture is tailored to enhance deep learning processes, enabling more layers and neurons in neural networks. This results in the creation of more accurate and sophisticated AI models, which have applications across various industries, including healthcare, finance, and autonomous systems.
Energy Efficiency: AI computations are notorious for their energy-intensive nature. QuantumLeap addresses this challenge by employing quantum coherence properties to significantly reduce energy consumption during AI processing. This energy-efficient design not only reduces operational costs but also aligns with sustainability efforts.
AI at the Edge: QuantumLeap's compact design allows for efficient integration into edge devices, bringing AI processing closer to the data source. This is particularly advantageous for applications requiring real-time decision-making, such as autonomous vehicles and IoT devices.
Future-Proof Architecture: Google's QuantumLeap is engineered with scalability in mind. Its architecture can adapt to evolving AI paradigms and algorithms, ensuring that the chip remains relevant and effective in the face of rapidly advancing AI technologies.

Synergy between the Enterprise Suite and QuantumLeap AI Chip

The announcement of both the Enterprise Suite and the QuantumLeap AI Chip on the same day is not coincidental. The two innovations share a symbiotic relationship that promises to revolutionize the way businesses operate.

The Enterprise Suite's AI-driven tools can leverage the unparalleled processing power of QuantumLeap. This means that data analytics, customer engagement, and other AI-based functionalities will see exponential improvements in speed and accuracy. Similarly, the QuantumLeap AI Chip can enhance the AI capabilities within the Enterprise Suite, enabling businesses to develop and deploy more sophisticated AI models to gain deeper insights and deliver more personalized experiences to their customers.

Conclusion

Google's unveiling of the Enterprise Suite and the QuantumLeap AI Chip on August 29, 2023, signifies a watershed moment in the trajectory of technology and enterprise innovation. The Enterprise Suite empowers businesses with a comprehensive suite of tools that span productivity, security, analytics, and customer engagement. Paired with the QuantumLeap AI Chip, businesses can harness the power of quantum processing to elevate their AI capabilities to unprecedented levels of efficiency and sophistication.

As Google propels the boundaries of technological possibility, the Enterprise Suite and QuantumLeap AI Chip stand as a testament to the transformative potential of innovation. The convergence of these two groundbreaking offerings not only shapes the future of enterprise operations but also showcases Google's commitment to shaping a smarter, more connected world.

Midjourney prompt: “Google's New AI Enterprise Suite and AI Chip”
[not actually the product image]

August 30, 2023

Diary, Newsletter, Summary

Global Market Comments
August 30, 2023
Fiat Lux

Featured Trades:

(GOOGLE’S MAJOR BREAKTHROUGH IN QUANTUM COMPUTING),
(GOOGL), (IBM)

CLICK HERE to download today's position sheet.

Google’s Major Breakthrough in Quantum Computing

Diary, Newsletter, Research

I have been following quantum computing since they moved from the theoretical to the practical about five years ago.

The reason is very simple. They promise to bring a 1 trillion-fold increase in computing power at zero cost, promising to solve in seconds some of the world’s most vexing problems.

They also have the potential to ramp the stock market up at least ten times over the next decade and bring on a new golden age. No kidding!

Last week an academic paper leaked and was quickly withdrawn suggesting that Google has accomplished a major breakthrough in the field.

Google claims to have built the first quantum computer that can carry out calculations beyond the ability of today’s most powerful supercomputers, a landmark moment that has been hotly anticipated by researchers.

A paper by Google’s researchers was briefly posted earlier this week on a NASA website before being removed, claiming that their processor was able to perform a calculation in three minutes and 20 seconds that would take today’s most advanced classical computer, known as Summit, approximately 10,000 years. Yikes!

The researchers said this meant “quantum supremacy” when quantum computers carry out calculations that had previously been impossible, had been achieved. This dramatic speed-up relative to all known classical algorithms provides an experimental realization of quantum supremacy on a computational task and heralds the advent of a much-anticipated computing paradigm. This experiment marks the first computation that can only be performed on a quantum processor.

The system can only perform a single, highly technical calculation, according to the researchers, and the use of quantum machines to solve practical problems is still years away. But the Google researchers called it “a milestone towards full-scale quantum computing”.

They also predicted that the power of quantum machines would expand at a “double exponential rate”, compared to the exponential rate of Moore’s Law, which has driven advances in silicon chips in the first era of computing. That means a potential doubling of computing power every nine months with a halving of cost.

While prototypes of so-called quantum computers do exist, developed by companies ranging from IBM (IBM) to start-ups such as Rigetti Computing, they can only perform the same limited tasks classical computers can, albeit quicker. There is also a huge problem accessing stored data. Quantum computers, if they can be built at scale, will harness properties that extend beyond the limits of classical physics to offer exponential gains in computing power.

A November 2018 report by the Boston Consulting Group said they could “change the game in such fields as cryptography and chemistry (and thus material science, agriculture, and pharmaceuticals) not to mention artificial intelligence and machine learning . . . logistics, manufacturing, finance, and energy”.

Unlike the basic binary elements of classical computers, or bits, which represent either zeros or ones, quantum bits, or “qubits”, can represent both at the same time. By stringing together qubits, the number of states they could represent rises exponentially, making it possible to compute millions of possibilities instantly.

Some researchers have warned against overhyping the quantum supremacy, arguing that it does not suggest that quantum machines will quickly overtake traditional computers and bring a revolution in computing. Led by John Martinis, an experimental physicist from the University of California, Santa Barbara, Google first predicted it would reach quantum supremacy by the end of 2017. But the system it built, linking together 72 qubits proved too difficult to control. It eventually revamped the system to create a 53-qubit design it codenamed Sycamore.

The system was given the task of proving that a random-number generator was truly random. Though that job has little practical application, the Google researchers said that “other initial uses for this computational capability” included machine learning, materials science, and chemistry.

“It’s a significant milestone, and the first time that somebody has shown that quantum computers could outperform classical computers at all,” said Steve Brierley, founder of quantum software start-up Riverlane, who has worked in the field for 20 years and is an adviser on quantum technologies to the UK government. “It’s an amazing achievement.”

To illustrate where we are with Quantum computers today, think of it as 1945, when only five mainframe computers existed in the world, all in the US and England. That’s when IBM founder Thomas Watson famously predicted that “The total market for computers is five.”

Oops.

August 30, 2023 - Quote of the Day

Diary, Newsletter, Quote of the Day

“The stock market is very much a mood ring,” said Josh Brown, of Ritholtz Wealth Management.

August 29, 2023

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
August 29, 2023
Fiat Lux

Featured Trade:

(WEIGHTY RETURNS)
(NVO), (LLY), (SNY), (AMGN), (PFE), (AZN)

Weighty Returns

Biotech Letter

These days, the narrative around transformative weight-loss drugs just got a little juicier. Here's the lowdown: Heart-failure patients are now giving a nod to Novo Nordisk’s (NVO) Wegovy. But, why?

The intel shows that the overweight community, grappling with heart woes, noticed a stamina uptick and weight drop when on Wegovy. The buzz was so compelling that it got its spotlight moment at the European Society of Cardiology Congress in Amsterdam. Plus, the New England Journal of Medicine gave it some ink.

Dive into the numbers, and you'll find that out of about 530 individuals with hearts not really pulling their weight (pun intended), the Wegovy brigade shed 13% of their body weight. That’s in stark contrast to the 3% that the placebo group managed.

More walking, less heart huffing-puffing - Wegovy users clocked in 17 times more steps on the treadmill and showcased fewer heart hiccups. Oh, and fewer side effects? Check.

Rewinding the tape, GLP-1 drugs initially stepped into the arena as the remedy for Type-2 diabetes. But then, surprise! Novo’s Ozempic and Eli Lilly’s (LLY) Mounjaro became the talk of the town. Not just because they were treating diabetes, but because those popping them shed an eye-catching 15% to 20% of their body weight. That's blockbuster material right there.

Eventually, Novo bagged the FDA's green light first for weight loss with Wegovy, and its demand skyrocketed so much so that medical maestros started prescribing Ozempic and Mounjaro to folks with weight woes. Now, all eyes are on the FDA's next move concerning Lilly’s weight-loss contender.

Now, here’s the kicker. This isn’t Wegovy’s first rodeo in the spotlight. Earlier this month, eyebrows were raised when it was revealed that these new kids on the block, known as GLP-1 agonists, might be the next superhero squad against a gamut of diseases.

Yet, GLP-1 might not just stop at obesity and heart diseases. It can also combat a spectrum of illnesses, including Alzheimer's. As expected, Novo and Lilly are doubling down on this potential, exploring these drugs' impact on liver and kidney diseases. As the benefits of GLP-1s unfold, insurers will probably be queuing up to offer coverage.

Let’s paint a clearer picture in terms of market potential.

Nearly 42% of U.S. adults grapple with obesity. The World Obesity Atlas dropped a bombshell—by 2035, over 4 billion global citizens might be tipping the scales, adding an astronomical $4 trillion in health costs.

The repercussions? Beyond the obvious heart diseases, strokes, and type 2 diabetes, they are also prone to mental health challenges, like depression and anxiety.

The economic ripples? Staggering. A drug that can be the silver bullet for such a widespread health epidemic could be the next Wall Street darling.

The next 10 years will likely see the GLP-1 agonists market touching an annual $86 billion. Yet, these figures might be leaning heavily on diabetes and off-label prescriptions.

With the World Health Organization cautioning about a billion obese and 2 billion overweight individuals by 2030, it's clear—this market is about to get a whole lot bigger.

With promises like these, it's no shocker that investors are tossing their coins into the ring. Both Novo and Lilly have seen their valuations triple, and Lilly's net worth now towers over its peers at a staggering $500 billion, crowning it the globe's pharmaceutical kingpin.

However, it’s wise to remember that it's one thing to climb the mountain and another to stay on the summit. Even in this early stage, competitors have started to emerge, including Amgen (AMGN), Sanofi (SNY), AstraZeneca (AZN), and Pfizer (PFE).

By 2025, the biopharma giants could potentially unveil their very own GLP-1-based wonder drugs for obesity, chipping away a quarter of Novo and Lilly's market dominance by 2032.

In the ever-evolving theater of biopharma, GLP-1 agonists, led by stalwarts like Wegovy, are emerging as the new front-runners. While the rewards seem tantalizingly vast, savvy investors know the pharmaceutical landscape is punctuated with highs and inevitable lows.

And here's a golden nugget: in the dynamic world of stock trading, every dip is an opportunity disguised as a setback. So, if you're seeking a stock market mantra for this burgeoning sector, remember to buy on the ebb, not the crest. It's in these valleys that fortunes are made, setting the stage for robust returns. Dive in wisely.

Trade Alert - (ABNB) August 29, 2023 - STOP LOSS - SELL

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

August 29, 2023

Diary, Newsletter, Summary

Global Market Comments
August 29, 2023
Fiat Lux

Featured Trades:

(LAST CHANCE TO ATTEND THE WEDNESDAY, SEPTEMBER 6, 2023 SAN DIEGO, CALIFORNIA STRATEGY LUNCHEON)
(A NEW THEORY OF EQUITIES)

CLICK HERE to download today's position sheet.

SOLD OUT - Wednesday, September 6, 2023 San Diego, California Global Strategy Luncheon

Diary, Luncheon, Newsletter

Come join me for lunch at the Mad Hedge Fund Trader’s Global Strategy Update, which I will be conducting in San Diego California at 12:00 noon on Wednesday, September 6, 2023.

The event will be held at a famous downtown San Diego restaurant with a spectacular harbor view. An excellent meal will be followed by a wide-ranging discussion and an extended question-and-answer period.

I’ll be giving you my up-to-date view on stocks, bonds, currencies, commodities, precious metals, and real estate. And to keep you in suspense, I’ll be throwing a few surprises out there too. Tickets are available for $279.

I’ll be arriving on time and leaving late in case anyone wants to have a one-on-one discussion, or just sit around and chew the fat about the financial markets.

The lunch will be held at an exclusive private restaurant in the downtown San Diego. The precise location will be emailed with your purchase confirmation.

I look forward to meeting you, and thank you for supporting my research.

To purchase tickets for the luncheons, please click the BUY NOW! button above or click here.

A New Theory of Equities

Diary, Newsletter

So far, 2023 is playing out just as I expected. A fantastic first half is being followed by a flat second half. Since the October 15 bottom, the Dow Average has risen by an eye-popping 3,000 points.

Followers of the Mad Hedge Fund Trader are already up by 60% so far in 2023.

However, I have been getting some pushback from some of my readers, especially the many new ones. Yes, the Dow Average is still off 2,500 points from its all-time high, after one of the sharpest selloffs in history.

However, we are only just getting started.

While climbing the base of Italy’s Cinque Torre recently at 9,000 feet (where I always get my best ideas), I had an epiphany.

I finally realized that nothing less than a New Theory of Equities was needed to get followers to understand WHY the Dow will rise from 34,500 to 240,000 by 2030, a gain of 695%. If I’m wrong, it will happen by 2031 or 2032.

It’s really very simple. Recall the laws of supply and demand?

From 2010 to 2020, roughly $6 trillion was invested in financial assets. Because the Great Recession and the 2008-9 crash had just happened, some 94% of this money went into bonds, while only 6% went to equities.

During the entire decade, portfolio managers, strategists, and hedge fund managers pronounced that bonds were overpriced and would imminently crash.

Instead, they went up for ten years.

Fast forward to 2021. A new decade has begun and bonds around the world were offering negative inflation-adjusted real returns. The planet was massively overweight bonds.

Many people don’t realize how stupidly low-interest rates still are right now. Triple “C” rated bonds are yielding what Triple “A” paper was a decade ago, about 7.5%.

I looked at municipal bond yields the other day and my eyes almost popped out of my head when I saw 2.45%. This is a yield that is so low that it is beyond any economic rationale.

So, what happens next.?

Let’s say that those bond/equity cash flow weightings reverse, that all new investment for the coming decade goes 94% into equities and 6% into bonds. Stock markets would rise for the decade while bonds fall. There’s your Dow at 240,000 right there.

Portfolio managers, strategists, and hedge fund managers predicting that stocks are overpriced and ready for a crash will be wrong for ten years. We won’t be massively overweight equities until 2030.

They are wringing their hands that stock prices have outrun fundamentals. In fact, the opposite is true. Fundamentals are outrunning stock prices….in a big way. Productivity and profit margins are exploding. Think AI, quantum computers, and rapid robotization.

Traditional asset managers would correctly point out that price-earnings multiples are not exactly cheap. And they’d be right if you were only looking at tech growth stocks, the market leaders since 2009. The big caps are priced at mid-20s multiples.

This ignores the huge chunk of the market, the value stocks, that are selling at low teens or single-digit multiple and basically haven’t moved in a decade.

What happens next is that value stock multiples rise to match those of the FANG. Add in earnings growth and that gets you to 240,000 also. By the way, in this scenario price earnings rise a lot, from the current 20 to 30, 35, or even 40.

I’ve seen it all before.

The fact is that American companies cut costs so dramatically since 2020 that they have spectacular earnings leverage in 2023 and beyond. This year, it was cut, or die. Many US companies are now over-prepared for a recession that may not actually happen.

Where are the breadlines and soup kitchens?

Except that this time it’s different.

Remember the 2009 Obama stimulus package? It amounted to a measly $831 billion because Republicans were doing everything they could to block it and Obama was new at the job. Only major banks, brokers, insurance companies, and car makers got bailed out. The rest of us were left to twist in the wind.

This time, the aggregate stimulus is looking like $10 trillion by the time you add in packages 1,2,3,4, Covid-19 rescues, an infrastructure bill, and Biden’s latest $729 Climate/Inflation Fighting/Deficit Reducing bill which is only just now hitting the economy.

But wait, there’s more!

It gets better.

You have to live in Silicon Valley to know this, but the rate of technology innovation has increased by tenfold since the nineties and is far broader than ever imagined. You won’t believe what’s coming your way!

You might ask what happens if interest rates rise further, and they will. The answer here is simple: only invest in the non-borrowing part of the stock market. It turns out that all big tech companies are in fact are net lenders to the system because their cash flows are so enormous. That explains the “Magnificent Seven.”

Other industries benefit from rising rates, like banks, brokers, insurance companies, payday lenders, and money managers. Companies that DO borrow substantially you don’t want to buy anyway, as they are in the wrong industries.

Interest rates would have to get really high before they act as a drag on the stock market, like 6%, 7%, or 8% and that is probably a 2030 event.

The bottom line here is that we are about to see the biggest binge of equity buying in 50 years. Yes, it really WILL be a new American Golden Age and Roaring Twenties.

Start practicing that Charleston!

Yes, stocks are about to become what bonds were in 2010.

I have run this scenario past several of my big-time hedge fund buddies and they ask why I’m being so conservative. They are looking at a Dow Average of 300,000 or 400,000 by 2030 if everything plays out as I expect.

I guess I’m just a conservative kind of guy. Old age and arthritis will do that to a person. Even one that climbs mountains.

Is That A 240,000 Dow?

On Cortina’s Cinque Torre